References
Liu L, Okada S, Kong X-F, Kreins AY, Cypowyj S, Abhyankar A, et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med. 2011;208(8):1635–48. https://doi.org/10.1084/jem.20110958.
Toubiana J, Okada S, Hiller J, Oleastro M, Gomez ML, Becerra JCA, et al. Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype. Blood. 2016;127:3154–64. https://doi.org/10.1182/blood-2015-11-679,902.
Mizoguchi Y, Tsumura M, Okada S, Hirata O, Minegishi S, Imai K, et al. Simple diagnosis of STAT1 gain-of-function alleles in patients with chronic mucocutaneous candidiasis. J Leukoc Biol. 2014;95(4):667–76. https://doi.org/10.1189/jlb.0513250.
Chandrasekaran P, Zimmerman O, Paulson M, Sampaio EP, Freeman AF, Sowerwine KJ, et al. Distinct mutations at the same positions of STAT3 causes either loss or gain of function. J Allergy Clin Immunol. 2016;138(4):1222–1224.e2. https://doi.org/10.1016/j.jaci.2016.05.007.
Tabellini G, Vairo D, Scomodon O, Tamassia N, Ferraro RM, Patrizi O, et al. Impaired NK cell functions in patients with STAT1 gain-of function mutations. J Allergy Clin Immunol. 2017;140(2):553–564.e4. https://doi.org/10.1016/j.jaci.2016.10.051.
Acknowledgements
We acknowledge Dr. Lorena Regairaz for her contribution with Patient 3 medical records and Marianela Sanz for her technical assistance.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declared that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Bernasconi, A.R., Yancoski, J., Villa, M. et al. Increased STAT1 Amounts Correlate with the Phospho-STAT1 Level in STAT1 Gain-of-function Defects. J Clin Immunol 38, 745–747 (2018). https://doi.org/10.1007/s10875-018-0557-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10875-018-0557-0